Clinically, BRCA1/2-mutated breast tumors tend to be classified as TNBC invasive ductal carcinoma with high nuclear grade while BRCA1/2-mutated ovarian tumors are predominantly classified as HGSOC [78,79,80]. This evidence concerns the gene BRCA1 and ovarian neoplasm.